An Unwelcome Interruption: Cancer Harms Both Health and Social Lives of Young People

For adolescents and young adults with cancer, bouncing back to a regular social life after treatment doesn’t always happen without help, a new study finds.

7:00 AM

Author | Beth Uznis Johnson

A cancer diagnosis is difficult at any age, but for adolescents and young adults, the experience might have long-lasting social implications.

MORE FROM THE LAB: Subscribe to our weekly newsletter

These individuals have lower social functioning than their healthy peers, a new study finds. And the disruption to social life lasts beyond cancer treatment if the patient perceives receiving little support.

Bradley Zebrack, Ph.D., a professor and researcher at the University of Michigan School of Social Work and Rogel Cancer Center, chose to study the effects of cancer on young people after his own experience with the disease at 25.

Rather than focusing on his job and girlfriend of nine months, a Hodgkin lymphoma diagnosis forced him to stop working and move back in with his family. He recalls having to miss a July Fourth celebration because he felt too sick.

"That was the first time I realized, wow, this experience is really isolating," Zebrack says. "Years later, when I became an academic and made young people the focus of my research, I found it was a common experience. And a lot of young people continue to have the experience as they got older."

The study, which was published in the journal Cancer, defines social functioning as "those activities considered essential for performance of the several roles which each individual by virtue of his membership in social groups is called to carry out."

Researchers surveyed 215 adolescents and young adults (ages 14 to 39) with cancer. A total of 141 patients completed a self-reported measure of social functioning within the first four months of diagnosis and again 12 and 24 months later. For example, did students typically attend class, interact with peers, attend social gatherings and form attitudes and opinions that would shape their future lives?

The results indicate a cancer diagnosis can limit the social life of a young person, with social functioning still disrupted two years after diagnosis. Patients struggle to return to work or school, feel isolated and experience increased risk of depression and anxiety.

Improving young lives now

Zebrack says there is potential to help young people with cancer during this crucial time in physical and social development. A growing body of research shows a positive impact of age-specific programs designed to help young people reintegrate into their lives after cancer.

SEE ALSO: Why So Many Cancer Drugs Fail in Clinical Trials

The U-M Rogel Cancer Center is one of many centers across the United States with cancer programs designed for young adults. The Sarcoma Survivorship Program was established by Laurence Baker, D.O., to address the long-term health care needs of sarcoma cancer survivors no longer in active treatment. The clinic is open to sarcoma survivors 18 years and older and to patients transitioning from pediatric to adult medical care.

Other programs in the young adult space can help as well. Outdoor adventure cancer therapy programs such as First Descents offer trips involving kayaking, rock climbing and surfing to help survivors reintegrate.

"Emerging programs that are specific to the adolescent and young adult experience are really important," Zebrack says. "For example, the Stupid Cancer website for young adults. They have a program called Instapeer where you can get instantly matched up with someone with cancer like you."

Zebrack's past research on young adults with cancer suggests that participation in age-specific programs can improve symptoms of depression and maintain positive results for at least one month afterward. He has also studied the improvements in patient outcomes and reductions in cost when a focus is placed on psychosocial care in addition to medical treatment.

"I'm all for research and investigating the potential cures for cancers," he says. "But the ability to impact and improve the lives of people going through cancer right now should also be a focus of research so we can see the payback of our investment in improving young lives."


More Articles About: Rounds Cancer Survivorship and Long-Term Follow-Up Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories
Health Lab
How the Sex Talk Differs for Young Adults with Cancer
A new study finds potential to help adolescents and young adults transition to healthy sex lives after cancer treatment ends.
Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Father’s cancerous brain tumor found weeks after the birth of his daughter
Father’s cancerous brain tumor found weeks after the birth of his daughter
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers